MET Stock Analysis: Buy, Sell, or Hold?
MET - MetLife, Inc.
$80.89
1.11 (1.39%)
▲
5d:
+3.73%
30d:
+3.6%
90d:
+2.94%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Get Alerted When MET Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MET is fairly valued with market pricing in 0.0% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: MET is fairly valued with market pricing in 0.0% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$114.68
Based on 7.8% avg growth
INTRINSIC VALUE TODAY
$71.21
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MET is currently trading at $80.89, which is considered extended relative to its 30-day fair value range of $74.98 to $79.68. The stock's valuation (Forward PE: 7.3) is in line with its historical norms (7.2). At these levels, the market is pricing in 0.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MET is in a downtrend. The price is approaching resistance at $81.59. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $90.31 (+13.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MET is in a downtrend. The price is approaching resistance at $81.59. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $90.31 (+13.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$74.98 -
$79.68
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
49.5%
Protect Your Profits
Holding MET? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($90.31)
- NEUTRAL: Market pricing in 0.0% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$74.98 -
$79.68
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$76.64
Resistance Level
$81.59
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.26
Wall Street Target
$90.31
(+13.2%)
Revenue Growth (YoY)
2.7%
Earnings Growth (YoY)
35.9%
Profit Margin
4.7%
PE vs Historical
7.3 vs 7.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
0%
(market-implied from PE analysis)
1-Year Target
$79.78
(0%)
2-Year Target
$79.78
(0%)
3-Year Target
$79.78
(0%)
3-Yr Target (if PE normalizes)
(PE: 7→7)
PE COMPRESSION
$79.08
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 11.5%)
$336.24
(+322%)
Base:
(SPY PE: 7.3, Growth: 11.5%)
$110.66
(+39%)
Bear:
(PE: 6.2, Growth: 11.5%)
$94.06
(+18%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (15x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 15.32 | Current EPS (TTM): $5.17
Bull Case
$174.20
(+118%)
Analyst growth 100.0%, PE expands to 16.9
Base Case
$158.36
(+99%)
Market implied 100.0%, PE stable at 15.3
Bear Case
$53.84
(-33%)
Severe decline -20.0%, PE contracts to 13.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 18, 2026 11:28 AM ET
Data refreshes hourly during market hours. Next update: 12:28 PM
Data refreshes hourly during market hours. Next update: 12:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MET showing a specific setup today?
Insider Activity (6 Months)
2
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Ro Khanna
SELL
2026-03-23
Ro Khanna
BUY
2026-03-10
Top Rated Insurance - Life Stocks
Top-rated stocks in Insurance - Life by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
UNM
Unum Group |
BUY
12 analysts |
$97 | 61 BUY |
|
ABL
Abacus Life Inc. |
STRONG BUY
5 analysts |
$14 | 58 HOLD |
|
MFC
Manulife Financial Corp |
BUY
13 analysts |
$35 | 51 HOLD |
|
GL
Globe Life Inc |
BUY
10 analysts |
$175 | 58 HOLD |
|
PRU
Prudential Financial, In… |
SELL
16 analysts |
$100 | 65 BUY |
Advanced MET Option Strategies
Professional options setups generated by AI based on today's MET price and gamma walls.
